News and Trends 17 Sep 2019
European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm
Genmab, GeNeuro and other companies presented their latest data on next-generation treatments for multiple sclerosis at a conference in Stockholm. …
GeNeuro
- Latest Posts
News and Trends 12 Mar 2019
Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis
An antibody that blocks the action of a hidden viral protein encoded by our genome shows encouraging signs of slowing…
More News! 26 Mar 2018
Attacking an Ancient Virus Slows Multiple Sclerosis in Phase II
GeNeuro has released Phase IIb data showing that its antibody can reduce brain damage in patients with multiple sclerosis by…
News and Trends 26 Feb 2018
This Multiple Sclerosis Drug Could Help to Fight Another Autoimmune Disease
The FDA has awarded Orphan Drug Designation to GeNeuro's antibody for the treatment of a rare autoimmune disease following promising…
ADVERTISEMENT
More News! 1 Nov 2017
Swiss Biotech & French Pharma Reverse Damage in Multiple Sclerosis
A candidate multiple sclerosis treatment from GeNeuro and its partner Servier showed some remyelination in a post hoc analysis of Phase IIb…
Best in Biotech 30 May 2017
In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight
Geneva is the largest city in French-speaking Switzerland, a financial powerhouse, home to the United Nations and known as the…
In Depth 25 Apr 2017
How Biotech is Mastering Multiple Sclerosis: A Review
With last month’s FDA approval, Ocrevus (ocrelizumab), became the first drug for primary-progressive multiple sclerosis. Roche may be the first,…
News and Trends 30 Sep 2016
Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment
GeNeuro is developing a unique treatment for multiple sclerosis. We interviewed Miguel Payro, the company's CFO, who explained its advantageous position against big…
News and Trends 16 Apr 2016
First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!
We last wrote about GeNeuro in January, when they announced the launch of an IPO for their Multiple Sclerosis phase…
News and Trends 15 Dec 2014
Will there be a New Merck-Serono?
GeNeuro SA has signed a unique partnership with Servier. The French pharmaceutical giant have bought an option for €38M on…
